Immuno-Oncology Across Cancer Types

There is significant research ongoing in Immuno-Oncology around the world. Bristol-Myers Squibb has an extensive research program with several I-O agents across multiple tumor types. Evidence of tumor-mediated inhibition of the immune system has been observed in the following advanced cancers.38-59

Tumor Type Infiltrating Immune
Cells Reported
Evidence of Tumor-Associated
Immunosuppression Reported
Tumor-Immune System Interactions
Known to Correlate with
Clinical Prognosis
Bladder
Breast
Colorectal
Esophageal
Gastric
Head & Neck Cancer
Hepatocellular
Leukemia    
Lung Cancer
Lymphoma    
Melanoma
Ovarian
Pancreatic  
Prostate  
Renal Cell Carcinoma
Across Cancer Types

Stay In The Know About I-O (IMMUNO-ONCOLOGY)

Keep learning what is possible in this rapidly evolving field.

Sign Up for Email Updates - Plus Free Downloads